Huntington’s disease research news. In plain language. Written by scientists. For the global HD community.

Are you looking for our logo? You can download our logo and get information about how to use it on our sharing page

Articles with the topic: KMO

Prominent Huntington's disease researcher "fabricated data" in grant applications

Prominent Huntington's disease researcher "fabricated data" in grant applications

Dr Ed Wild on January 06, 2013

The National Institute for Health's Office for Research Integrity has ruled that Huntington's disease researcher Dr Paul Muchowski, formerly of the Gladstone Institutes at University of California San Francisco, committed "research misconduct by falsifying and fabricating data" in several applications for funding. What does this mean for Muchowski's published HD therapies research?

KMO inhibitor drug improves lifespan of Huntington's disease mice

KMO inhibitor drug improves lifespan of Huntington's disease mice

Dr Ed Wild on June 02, 2011

An enzyme called KMO, which alters the balance of harmful and protective brain chemicals, has been a focus of research into possible Huntington's disease treatments for several years. Now, the first positive results of a KMO inhibiting drug have been published in the scientific journal Cell. HDBuzz investigates...

CHDI Report: Day 3

CHDI Report: Day 3

Dr Jeff Carroll on February 10, 2011

Our third and final daily report from CHDI’s annual HD therapies meeting in Palm Springs, covering chemicals that can help neurons to survive, and insights into CHDI’s most advanced experimental drug programs.